Open AccessMortality During the First Year of Potent Antiretroviral Therapy in HIV-1-Infected Patients in 7 Sites Throughout Latin America and the Caribbean
Author(s) -
Suely Tuboi,
Mauro Schechter,
Catherine C. McGowan,
Carina César,
Alejandro Krolewiecki,
Pedro Cahn,
Marcelo Wolff,
Jean William Pape,
Denis Padgett,
Juan G. Sierra Madero,
Eduardo Gotuzzo,
Daniel R. Masys,
Bryan E. Shepherd
Publication year - 2009
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e3181a44f0a
Subject(s) - latin americans , hazard ratio , medicine , demography , confidence interval , mortality rate , antiretroviral therapy , caribbean region , viral load , human immunodeficiency virus (hiv) , immunology , philosophy , linguistics , sociology
Although nearly 2 million people live with HIV in Latin America and the Caribbean, mortality rates after initiation of highly active antiretroviral therapy (HAART) have not been well described.